Table 2.

Patient characteristics and cancer diagnoses of respondents to the 2010 Cancer Patient Experience Survey (CPES) and associations with post-sampling mortality and response rates.^a

	Sampling frame	Post-sampling deaths (N,%)		Respondents	Response rateb		Sampling frame	Post-sampling deaths (N,%)		Respondents	Response rateb
Age						Cancer
16–24	1,149	38	3.3	408	37.9	Ductal carcinoma in situ	955	4	0.4	732	77.8
25–34	2,212	61	2.8	992	47.4	Thyroid	780	8	1.0	458	61.3
35–44	5,983	205	3.4	3,239	57.0	Testicular	567	6	1.1	275	50.4
45–54	13,208	547	4.1	8,091	64.7	Melanoma	1,808	32	1.8	1,146	65.9
55–64	24,245	1,257	5.2	16,066	70.6	Breast	16,937	302	1.8	12,204	73.8
65–74	29,172	1,744	6.0	19,443	71.8	Bladder	10,544	311	2.9	6,591	65.4
75–84	19,468	1,488	7.6	11,570	65.4	Hodgkin’s lymphoma	946	18	1.9	509	55.3
85+	4,797	482	10.0	2,172	51.7	Ophthalmic and rarer CNS	194	4	2.1	108	63.2
						Endometrial	1,878	55	2.9	1,269	70.3
Gender						Ureter and rarer urological	544	20	3.7	313	60.2
Men	48,497	3,179	6.6	29,067	65.1	Laryngeal	550	20	3.6	319	61.3
Women	51,737	2,643	5.1	32,914	67.9	Prostate	7,343	302	4.1	4,710	68.2
						Non-Hodgkin lymphoma	5,805	225	3.9	3,768	68.6
Ethnicity						Rectal	4,923	213	4.3	3,187	68.4
White	94,447	5,472	5.8	59,382	67.6	Anal	355	15	4.2	208	62.3
Mixed	376	21	5.6	188	54.2	Colon	6,874	319	4.6	4,619	71.2
Asian	2,386	145	6.1	1,022	46.2	Multiple myeloma	4,098	189	4.6	2,569	66.5
Black	1,933	124	6.4	857	48.5	Gynaecological NOS	79	4	5.1	51	68.0
Chinese	228	17	7.5	118	56.2	Vulval/vaginal	417	22	5.3	253	65.7
Other	864	43	5.0	414	52.0	Leukaemia	4,144	233	5.6	2,375	61.8
						Bone sarcoma	320	15	4.7	156	51.8
Deprivationc						Renal	1,422	92	6.5	843	64.6
Most affluent	20,809	1,079	5.2	13,932	71.3	Oropharyngeal	2,016	132	6.5	1,147	62.0
2	21,655	1,145	5.3	14,093	69.6	Soft tissue sarcoma	873	58	6.6	494	62.6
3	20,803	1,175	5.6	13,197	68.0	Ovarian	2,620	185	7.1	1,627	68.0
4	19,369	1,167	6.0	11,455	63.8	Small-intestine	382	30	7.9	210	60.9
Least affluent	17,598	1,256	7.1	9,304	58.1	Cervical	729	48	6.6	359	53.4
						Hepato-biliary	993	109	11.0	488	56.0
						Any other cancer diagnosis	1,166	119	10.2	599	59.2
						Stomach	1,749	199	11.4	936	61.7
						Secondary	6,974	803	11.5	3,836	62.8
						Oesophageal	2,457	339	13.8	1,280	61.5
						Lung	5,873	878	14.9	3,050	61.8
						Mesothelioma	565	92	16.3	315	67.3
						Pancreatic	1,199	231	19.3	555	58.4
						Brain	1,155	190	16.5	422	44.7

^aThe sample described here are the 100,234 patients with complete hospital record ethnicity, and deprivation information.

^bCalculated as the proportion of people in each group who responded to the survey after excluding ineligible patients (those who had died, and other ineligible patients).

^cMeasured using the index of multiple deprivation, and quantile-defining cut points 8.257, 13.525, 20.741, and 33.511.